Theranos Investor Conference Presentation Deck
August 2016, 88 slides
  1. Theranos
  2. Investor Conference Presentation Decks
science technology the of laboratory testing | Theranos
scientific exchange | Theranos
our mission is to make actionable health | Theranos
technologies | Theranos
technologies | Theranos
technologies | Theranos
technologies | Theranos
technologies | Theranos
technologies | Theranos
| Theranos
and integration of detection systems | Theranos
and integration of processing modules | Theranos
sample processing unit | Theranos
sample processing unit | Theranos
sample processing unit | Theranos
faceted material handling robot allows versatility | Theranos
cartridge carries sample and reagents | Theranos
cartridges to the assays | Theranos
cartridges to the assays | Theranos
| Theranos
| Theranos
virtual analyzer enables remote processing and analysis | Theranos
| Theranos
| Theranos
| Theranos
hematology | Theranos
| Theranos
clinical chemistry | Theranos
| Theranos
| Theranos
| Theranos
clinical chemistry precision and method comparison | Theranos
clinical chemistry spectrophotometer a | Theranos
clinical chemistry precision study overview eel a | Theranos
precision study design | Theranos
clinical chemistry precision results meet performance criteria | Theranos
clinical chemistry method comparison study overview | Theranos
potassium on correlates to comparator method for venous plasma | Theranos
on correlate to comparator method for venous plasma i | Theranos
assay accuracy confirmed with standard | Theranos
clinical chemistry assays on meet allowable total error criteria | Theranos
immunochemistry precision and method comparison | Theranos
immunochemistry luminometer fluorometer | Theranos
immunochemistry precision study overview | Theranos
immunochemistry precision results show acceptable | Theranos
immunochemistry method comparison study overview | Theranos
immunochemistry measurements are consistent with comparator method | Theranos
hematology and immunology precision and method comparison | Theranos
hematology and immunology cytometer | Theranos
hematology and immunology assay methodology | Theranos
hematology and immunology image processing | Theranos
cell cell cells lymphocyte subset precision study overview | Theranos
lymphocyte subset precision results meet | Theranos
lymphocyte subset method comparison study overview | Theranos
lymphocyte subset counts correlate with comparator method | Theranos
lymphocyte subset counts correlate with comparator method | Theranos
lymphocyte subset counts meet allowable total error criteria | Theranos
molecular biology acid amplification naa assay in venous serum on performance characteristics | Theranos
acid amplification naa fluorescence based isothermal detector and | Theranos
naa assays methodology | Theranos
molecular biology naa assay is sensitive for the target gene | Theranos
molecular biology naa assay does not cross react or show interference with pathogens | Theranos
molecular biology naa assay does not cross react or show interference with pathogens | Theranos
molecular biology naa assay does not cross react or show interference with pathogens | Theranos
molecular biology naa assay inclusive for other strains | Theranos
molecular biology naa assay shows no | Theranos
naa assay clinical study overview | Theranos
| Theranos
sample processing unit | Theranos
| Theranos
capillary collection optimization of collection variables | Theranos
sample collection device | Theranos
sample collection device design | Theranos
collection and activation | Theranos
collection and activation | Theranos
| Theranos
sample container box for shipping | Theranos
matrix comparison on | Theranos
panel matrix comparison study overview | Theranos
capillary total cholesterol correlates to venous | Theranos
panel capillary bias summary | Theranos
lymphocyte subset matrix comparison study overview | Theranos
capillary cell count correlates to venous | Theranos
lymphocyte subset capillary bias summary | Theranos
naa assay clinical study overview | Theranos
| Theranos
technologies wee nes | Theranos
| Theranos
See More
Theranos
Investor Conference Presentation Decks
Related Content
Articles:
On the Road to Failure
Deck Collections:
Ancient Relics and Dusty Old Slides
Largest corporate collapses and scandals
Explore Topics
Blood
Recent decks by Theranos
Start Up
June 2006
See all presentations by Theranos (2 decks)
Recent decks by Theranos
See all presentations (2 decks)
Start Up
June 2006
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io